ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,000 | +25.0% | 6,554 | +61.0% | 0.00% | – |
| Q2 2023 | $32,000 | – | 4,071 | +67750.0% | 0.00% | – |
| Q1 2023 | $0 | -100.0% | 6 | -96.9% | 0.00% | – |
| Q4 2022 | $1,000 | -66.7% | 191 | -82.4% | 0.00% | – |
| Q3 2022 | $3,000 | +50.0% | 1,087 | +110.3% | 0.00% | – |
| Q2 2022 | $2,000 | -90.5% | 517 | -86.9% | 0.00% | – |
| Q1 2022 | $21,000 | -76.7% | 3,942 | -35.4% | 0.00% | – |
| Q4 2021 | $90,000 | +28.6% | 6,099 | +81.0% | 0.00% | – |
| Q3 2021 | $70,000 | +94.4% | 3,370 | +66.8% | 0.00% | – |
| Q2 2021 | $36,000 | -26.5% | 2,020 | +1.5% | 0.00% | – |
| Q1 2021 | $49,000 | +188.2% | 1,991 | +291.2% | 0.00% | – |
| Q4 2020 | $17,000 | +1600.0% | 509 | +2323.8% | 0.00% | – |
| Q3 2020 | $1,000 | – | 21 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 602,272 | $3,643,746 | 14.84% |
| Column Group LLC | 3,568,181 | $21,587,495 | 14.33% |
| Nextech Invest Ltd. | 4,285,714 | $25,928,570 | 7.86% |
| Prosight Management, LP | 2,579,802 | $15,607,802 | 4.95% |
| Invus Financial Advisors, LLC | 1,007,575 | $6,095,829 | 3.82% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,123,345 | $6,796,237 | 2.06% |
| VR Adviser, LLC | 2,142,856 | $12,964,279 | 1.36% |
| Altium Capital Management LP | 418,706 | $2,533,171 | 1.32% |
| Euclidean Capital LLC | 1,978,820 | $11,971,862 | 1.31% |
| Frazier Life Sciences Management, L.P. | 2,142,855 | $12,964,273 | 0.86% |